BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3298705)

  • 21. Creutzfeldt-Jakob disease in a recipient of a dura mater graft processed in the US: cause or coincidence?
    Dobbins JG; Belay ED; Malecki J; Buck BE; Bell M; Cobb J; Schonberger LB
    Neuroepidemiology; 2000; 19(2):62-6. PubMed ID: 10686530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurosurgery and iatrogenic transmission of Creutzfeldt-Jakob disease.
    Newcombe RL
    Med J Aust; 1996 May; 164(10):603-4. PubMed ID: 8637464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiologic features of 65 Creutzfeldt-Jakob disease patients with a history of cadaveric dura mater transplantation in Japan.
    Nakamura Y; Yanagawa H; Kitamoto T; Sato T
    Epidemiol Infect; 2000 Aug; 125(1):201-5. PubMed ID: 11057978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Creutzfeldt-Jakob disease in a patient with a cadaveric dural graft.
    Miyashita K; Inuzuka T; Kondo H; Saito Y; Fujita N; Matsubara N; Tanaka R; Hinokuma K; Ikuta F; Miyatake T
    Neurology; 1991 Jun; 41(6):940-1. PubMed ID: 2046948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case-control study of Creutzfeldt-Jakob disease in Japan: transplantation of cadaveric dura mater was a risk factor.
    Nakamura Y; Oki I; Tanihara S; Ojima T; Yanagawa H; Kitamoto T; Sato T
    J Epidemiol; 2000 Nov; 10(6):399-402. PubMed ID: 11210109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dura mater-associated Creutzfeldt-Jakob disease: experience from surveillance in the UK.
    Heath CA; Barker RA; Esmonde TF; Harvey P; Roberts R; Trend P; Head MW; Smith C; Bell JE; Ironside JW; Will RG; Knight RS
    J Neurol Neurosurg Psychiatry; 2006 Jul; 77(7):880-2. PubMed ID: 16627534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Creutzfeldt-Jakob disease after receipt of a previously unimplicated brand of dura mater graft.
    Hannah EL; Belay ED; Gambetti P; Krause G; Parchi P; Capellari S; Hoffman RE; Schonberger LB
    Neurology; 2001 Apr; 56(8):1080-3. PubMed ID: 11320182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Creutzfeldt-Jakob disease and cadaveric dura mater grafts in Japan: an updated analysis of incubation time.
    Matsui S; Sadaike T; Hamada C; Fukushima M
    Neuroepidemiology; 2005; 24(1-2):22-5. PubMed ID: 15459505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probable Creutzfeldt-Jakob disease after a cadaveric dural graft.
    Lang CJ; Schüler P; Engelhardt A; Spring A; Brown P
    Eur J Epidemiol; 1995 Feb; 11(1):79-81. PubMed ID: 7489777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Creutzfeldt-Jakob disease after an embolization of intercostal arteries with cadaveric dura mater suggesting a systemic transmission of the prion agent.
    Defebvre L; Destée A; Caron J; Ruchoux MM; Wurtz A; Remy J
    Neurology; 1997 May; 48(5):1470-1. PubMed ID: 9153501
    [No Abstract]   [Full Text] [Related]  

  • 31. Creutzfeldt-Jakob disease in patients who received a cadaveric dura mater graft--Spain, 1985-1992.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Jul; 42(28):560-3. PubMed ID: 8326950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update: Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts--Japan, 1978-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(42):1152-4. PubMed ID: 18946463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Creutzfeldt-Jakob disease after Jannetta's operation with cadaveric dura mater graft: initial manifestations related to the grafted site.
    Nishida Y; Yamada M; Hara K; Tsunemi T; Yamawaki M; Shimokawa R; Okeda R; Tsutsumi T; Mizusawa H
    J Neurol; 2002 Apr; 249(4):480-3. PubMed ID: 11967658
    [No Abstract]   [Full Text] [Related]  

  • 34. Health Ministry denies fault on Creutzfeldt Jacob disease-linked dura mater transplants.
    Front Med Biol Eng; 2001; 10(4):368. PubMed ID: 11334177
    [No Abstract]   [Full Text] [Related]  

  • 35. Creutzfeldt-Jakob disease transmitted by a cadaveric dura mater graft.
    Yamada S; Aiba T; Endo Y; Hara M; Kitamoto T; Tateishi J
    Neurosurgery; 1994 Apr; 34(4):740-3; discussion 743-4. PubMed ID: 8008177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease.
    Noguchi-Shinohara M; Hamaguchi T; Kitamoto T; Sato T; Nakamura Y; Mizusawa H; Yamada M
    Neurology; 2007 Jul; 69(4):360-7. PubMed ID: 17646628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unconventional transmissible agents in dura mater: significance for iatrogenic Creutzfeldt-Jakob disease.
    Taylor DM; McConnell I
    Neuropathol Appl Neurobiol; 1996 Jun; 22(3):259-60. PubMed ID: 8804029
    [No Abstract]   [Full Text] [Related]  

  • 38. [Iatrogenic Creutzfeldt-Jakob disease].
    Nishizawa M
    Nihon Rinsho; 2011 Dec; 69 Suppl 10 Pt 2():415-8. PubMed ID: 22755225
    [No Abstract]   [Full Text] [Related]  

  • 39. Iatrogenic and zoonotic Creutzfeldt-Jakob disease: the Australian perspective.
    Collins S; Masters CL
    Med J Aust; 1996 May; 164(10):598-602. PubMed ID: 8637463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Creutzfeldt-Jakob disease transmitted by cadaveric dural graft: a case report].
    Takayama S; Hatsuda N; Matsumura K; Nakasu S; Handa J
    No Shinkei Geka; 1993 Feb; 21(2):167-70. PubMed ID: 8459905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.